(19)
(11) EP 1 272 615 A2

(12)

(88) Date of publication A3:
10.01.2002

(43) Date of publication:
08.01.2003 Bulletin 2003/02

(21) Application number: 01926403.5

(22) Date of filing: 21.03.2001
(51) International Patent Classification (IPC)7C12N 5/00, C12N 5/02, C12N 15/00, C12N 15/09, C12N 15/63, C12N 15/70, C12N 15/74, C12N 15/85, C12N 15/86, C12N 15/87, A01N 63/00, A61K 48/00
(86) International application number:
PCT/US0109/101
(87) International publication number:
WO 0107/0175 (27.09.2001 Gazette 2001/39)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 21.03.2000 US 191063 P

(71) Applicant: THE UNIVERSITY OF VIRGINIA PATENT FOUNDATION
Charlottesville,VA 22903 (US)

(72) Inventors:
  • CHUNG, Leland, W., K.
    Lovingston, VA 22949 (US)
  • KAO, Chinghai
    Charlottesville, VA 22903 (US)
  • GARDNER, Thomas, A.
    Zionsville, IN 46077 (US)
  • KO, Song-Chu
    Charlottesville, VA 22901 (US)

(74) Representative: Horner, Martin Grenville et al
Cruikshank & Fairweather19 Royal Exchange Square
Glasgow G1 3AEScotland
Glasgow G1 3AEScotland (GB)

   


(54) OSTEOCALCIN PROMOTER DIRECTED ADENOVIRUS REPLICATON FOR THERAPY